Regeneron Q1 profit soars

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Thursday, Regeneron Pharmaceuticals reported its Q1 profit surged as much as 78%, driven by strong demand recovery of its Eylea eye drug and ongoing strength in the Dupixent eczema drug's sales.
Back to articles

Actual Topics

Thu, 06 May 2021 12:00:29 GMT

BoE's policy remains unchanged

The Bank of England's MPC judged the existing monetary policy's stance to remain unchanged at 0.1%, seeking to meet the inflation target of 2%, according to an official statement.

Thu, 06 May 2021 10:23:25 GMT

IBM unveils new technology

On Thursday, IBM revealed a new 2-nanometer chip technology, which is bound to increase speeds of computing.

Subscribe to "Fundamental Analysis" feed

Subscribe
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.